Latest Breaking News On - Company or cognition - Page 1 : comparemela.com

Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease

Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Company-or-cognition
Cognition-therapeutics-inc
Amyloid-toxicity

Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease Seite 1

Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease Seite 1
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Company-or-cognition
Cognition-therapeutics-inc
Amyloid-toxicity

Cognition Therapeutics Releases New Episode Of "Conversations" Podcast: Protecting The Synapse From Amyloid Toxicity In Alzheimer's Disease

PURCHASE, N.Y., May 21, 2024 (GLOBE NEWSWIRE)

Jort-vijverberg
Mary-hamby
Anthony-caggiano
Amsterdam-alzheimer-center-at-neuroscience
Company-or-cognition
Cognition-therapeutics-inc
Health-care-disclaimer
Amyloid-toxicity
Cognition-therapeutics
Staff-neurologist
Amsterdam-alzheimer-center

Cognition Therapeutics Completes Enrollment in Phase 2 SHIMMER Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies

PURCHASE, N.Y., April 29, 2024 (GLOBE NEWSWIRE) Cognition Therapeutics, Inc. (the "Company" or "Cognition") CGTX, a clinical stage company developing drugs…

Company-or-cognition
Cognition-therapeutics-inc
News
Ggregator
Reaking-news
Uration
Media

Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer's disease

PURCHASE - Cognition Therapeutics, Inc., , a clinical stage company developing drugs that treat neurodegenerative disorders, provided a recap of the virtual KOL event hosted on April 12, 2024.

Amsterdam
Noord-holland
Netherlands
Anton-porsteinsson
Jort-vijverberg
Mike-moyer
Casey-mcdonald
Martinj-sadowski
Lisa-ricciardi
Company-or-cognition
Securities-exchange-commission
Cognition-therapeutics-inc